- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Cheyenne Peters
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola De Liban
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Jules Lutaba
- Kally Xu
- Kasey Nichols
- Kavisha Prajapati
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Walter Hsiang, MD
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- April 5, 2023
FAQ: Insurance Coverage for Pharmacy-Dispensed Medication Abortion
Read moreThe U.S. Food and Drug Administration (FDA) announced new changes to the mifepristone Risk Evaluation and Mitigation Strategy (REMS) in January 2023, opening the door to the expansion of medication abortion access through pharmacist dispensing. However, equitable abortion access under this model requires intentional benefit design in order to…
- April 4, 2023
NHeLP Comments on Coverage of Contraceptive Services Under the Affordable Care Act
Read moreSection 2713(a)(4) of the Public Health Service Act, and its implementing regulations, make access to contraception possible by ensuring that health plans in the individual and small group markets adequately cover contraception without cost-sharing—cost-sharing that would otherwise reduce use of this necessary service. In our comments, NHeLP strongly supports…
- April 3, 2023
National Health Law Program Comments on the DEA’s Proposed Rule on Telemedicine Prescribing of Controlled Medications
Read moreThe National Health Law Program (NHeLP) submitted comments on the Drug Enforcement Administration's (DEA) Notice of Proposed Rulemaking, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation." NHeLP believes that all people should have access to the health care…
- March 16, 2023
Protect Medicaid Funding series (2023)
Michelle Yiu, Emma Parker-Newton, David Machledt, Amy Chen, Madeline Morcelle, Héctor Hernández-Delgado, Catherine McKee, Mara Youdelman, Wayne Turner, Dania Douglas, and Charly Gilfoil Fact SheetRead moreA 2024 update of this series can be found here. In an updated series of fact sheets called Protect Medicaid Funding, NHeLP provides succinct analysis of the policy proposals that if enacted would jeopardize the health and financial security of the tens of millions of low-income individuals who depend…
- March 13, 2023
NHeLP Comments on the HHS Prior Authorization Proposed Rule (2023)
Read moreIn these comments on the Prior Authorization Proposed Rule, NHeLP urges HHS to go further to curb the abuse of prior authorization as a cost savings strategy that endangers patients’ health. NHeLP supports efforts to streamline prior authorization processing and bring greater transparency to denial rates and the clinical…
- March 7, 2023
National Health Law Program Comments on HHS’s Proposed Changes to Health Care Refusal Regulations
Read moreThe National Health Law Program submitted comments on the Department of Health and Human Services's (HHS) Notice of Proposed Rulemaking to implement federal health care refusal laws, called "Safeguarding the Rights of Conscience as Protected by Federal Statutes.” Our comments thank HHS for proposing to rescind the most harmful…
